XueBiJing Injection Versus Placebo for Critically Ill Patients with Severe Community-Acquired Pneumonia: A Randomized Controlled Trial.
Yuanlin Song,Chen Yao,Yongming Yao, Hui Han,Xiaodong Zhao,Kaijiang Yu,Luyi Liu, Ying Xu,Zhongmin Liu,Qingshan Zhou,Ying Wang,Zhuang Ma,Youguang Zheng,Dawei Wu,Zhongzhi Tang,Minzhou Zhang,Shuming Pan,Yanfen Chai,Yan Song,Jian Zhang,Lei Pan,Yi Liu,He Yu,Xuezhong Yu,Hong Zhang,Xiaoge Wang,Zhaohui Du,Xianyao Wan,Yijun Tang,Yingping Tian,Yimin Zhu,Hongliang Wang,Xiaoyan Yan,Zhi Liu,Boli Zhang,Nanshan Zhong,Hongcai Shang,Chunxue Bai Critical Care Medicine（2019）
关键词
28-day mortality rate,pneumonia severity index,randomized controlled trial,severe community-acquired pneumonia,XueBiJing injection
AI 理解论文
溯源树
样例
